Loveyouhealth Ltd 13831464 false 2023-02-01 2024-01-31 2024-01-31 The principal activity of the company is Retail sale via mail order houses or via Internet Digita Accounts Production Advanced 6.30.9574.0 true true 13831464 2023-02-01 2024-01-31 13831464 2024-01-31 13831464 bus:OrdinaryShareClass1 bus:OtherShareType 2024-01-31 13831464 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 13831464 bus:SmallEntities 2023-02-01 2024-01-31 13831464 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 13831464 bus:FilletedAccounts 2023-02-01 2024-01-31 13831464 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 13831464 bus:RegisteredOffice 2023-02-01 2024-01-31 13831464 bus:CompanySecretaryDirector1 2023-02-01 2024-01-31 13831464 bus:OrdinaryShareClass1 bus:OtherShareType 2023-02-01 2024-01-31 13831464 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13831464 countries:AllCountries 2023-02-01 2024-01-31 13831464 2022-01-06 2023-01-31 13831464 2023-01-31 13831464 bus:OrdinaryShareClass1 bus:OtherShareType 2023-01-31 13831464 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13831464

Loveyouhealth Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 January 2024

 

Loveyouhealth Ltd

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 4

 

Loveyouhealth Ltd

Company Information

Director

Mrs Uzma Chaudhri

Company secretary

Mrs Uzma Chaudhri

Registered office

128 City Road
London
EC1V 2NX

Accountants

A.Y.A Accountants Limited
82 Blackburn Road
Accrington
Lancashire
BB5 1LL

 

Loveyouhealth Ltd

(Registration number: 13831464)
Abridged Balance Sheet as at 31 January 2024

Note

2024
£

2023
£

Current assets

 

Stocks

500

-

Cash at bank and in hand

 

7,600

12,306

 

8,100

12,306

Creditors: Amounts falling due within one year

(3,500)

(7,963)

Total assets less current liabilities

 

4,600

4,343

Accruals and deferred income

 

(550)

(450)

Net assets

 

4,050

3,893

Capital and reserves

 

Retained earnings

4,050

3,893

Shareholders' funds

 

4,050

3,893

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 30 September 2024
 

.........................................
Mrs Uzma Chaudhri
Company secretary and director

 

Loveyouhealth Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
128 City Road
London
EC1V 2NX
England

These financial statements were authorised for issue by the director on 30 September 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Loveyouhealth Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

4

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary Share Capital of £1 each

1

1

1

1